Early Fibrin Biofilm Development in Cardiovascular Infections
Safae OukrichiD, Jane H. HongiD, Mariël Leon-GrootersiD, Wiggert A. van CappelleniD, Johan A. SlotmaniD, Gijsje Hendrika KoenderinkiD, Willem J. B. van WameliD, Moniek P.M. de MaatiD, Klazina KooimaniD, Kirby R. LattweiniD
Abstract
The single most common microbe causing cardiovascular infections is Staphylococcus aureus (S. aureus). S. aureus produces coagulase that converts fibrinogen to fibrin, which is incorporated into biofilms. This process aids in adherence to intravascular structures, defense against the host immune system, and resistance to antimicrobial treatment. Despite its significance, fibrin formation in S. aureus biofilms remains poorly understood. Therefore, this study aimed to elucidate the early development of cardiovascular biofilms. Clinically isolated coagulase-positive S. aureus and coagulase-negative Streptococcus gordonii (S. gordonii) from patients with cardiovascular infections, and a coagulase mutant S. aureus {Delta}coa, were grown in tryptic soy broth (TSB), Iscoves Modified Dulbeccos Medium (IMDM), and pooled human plasma, with or without porcine heart valves. Bacterial growth, metabolic activity, and bacterial fibrinogen utilization were measured over 24 hr at 37 {degrees}C. Time-lapse confocal microscopy was used to visualize and track biofilm development. S. aureus exhibited more growth in TSB and human plasma than S. gordonii and S. aureus {Delta}coa, but showed similar growth as S. aureus {Delta}coa in IMDM. Peak metabolic activity for all isolates was highest in TSB and lowest in human plasma. The presence of porcine valves caused strain-dependent alterations in time to peak metabolic activity. Confocal imaging revealed fibrin-based biofilm development exclusively in the coagulase-producing S. aureus strains. Between 2 and 6 hr of biofilm development, 74.9% (p=0.034) of the fibrinogen from the medium was converted to fibrin. Variations in fibrin network porosity and density were observed among different coagulase-producing S. aureus strains. Fibrin formation is mediated by S. aureus coagulase and first strands occurred within 3 hr for clinical strains after exposure to human plasma. This study stresses the importance of experimental design given the bacterial changes due to different media and substrates and provides insights into the early pathogenesis of S. aureus cardiovascular biofilms. HighlightsO_LIBacterial growth and activity are medium and substrate dependent C_LIO_LICoagulase is necessary for Staphylococcus aureus fibrin biofilm development C_LIO_LIFibrin strands begin forming in Staphylococcus aureus biofilms within 3 hours C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 1.44
- Field percentile
- top 21%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Staphylococcus aureus Biofilm Removal by Targeting Biofilm-Associated Extracellular Proteins
S. K. Shukla, T. S. Rao·bioRxiv·Jan 23, 2017
- Polymicrobial interactions between Staphylococcus aureus and Pseudomonas aeruginosa promote biofilm formation and persistence in chronic wound infections
Klara C. Keim, Mohini Bhattacharya, … Alexander R. Horswill·bioRxiv·Nov 4, 2024
- Assessment and Comparative Study of Biofilm Formation with frequency of Multi Drug Resistance in strains of Staphylococcus aureus
- The bacillithiol pathway is required for biofilm formation in Staphylococcus aureus
M. Gulati, J. M. Thomas, … C. J. Nobile·bioRxiv·Dec 16, 2018
- Extracellular membrane vesicles - previously unrecognized components of Staphylococcus aureus biofilms
Jinger Lei, Misaki Foster, … Xiaogang Wang·Journal of BacteriologyPeer-reviewed·Aug 7, 2026
- Plasmin-Mediated Processing of Clumping Factor A Impacts Bacterial, Aggregation and Abscess Formation during Staphylococcus aureus Infection
Mary B. Turley, Zhicheng Hu, … Joan A. Geoghegan·bioRxiv·Jun 30, 2025